Mayfair Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Mayfair Advisory Group's LLY Position: Q1 2026 in Review
Mayfair Advisory Group increased its Eli Lilly (LLY) stake by 1.3% in Q1 2026, buying an estimated $19.3K and bringing the position to 1,496 shares worth $1.38M. The position accounts for 0.48% of the portfolio, ranked #41.
Mayfair Advisory Group first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.6M in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Mayfair Advisory Group held 1,496 shares of Eli Lilly worth $1.38M as of Q1 2026.
- Mayfair Advisory Group bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
- Eli Lilly made up 0.48% of Mayfair Advisory Group's portfolio in Q1 2026, its #41 holding.
- Mayfair Advisory Group first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
- Mayfair Advisory Group's Eli Lilly position peaked at $1.6M in Q4 2025.
- 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Mayfair Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.